IL10 and inflammatory bowel disease: Motta et al. [73] demonstrated the efficacy of a recombinant L. lactis strain expressing human elafin anti-protease activity against inflammation in a mouse model of IBD, with similar protection properties to those of IL-10, also delivered by a recombinant L. lactis strain.